Search

Your search for "pbio" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Plans Expansion to Successful New Premium Collection

April 11, 2024

Pressure BioSciences (OTCQB: PBIO) and its wholly owned subsidiary, Uncle Bud’s, are expanding the Premium Collection of state-of-the-art nanoemulsified products. The line of Premium Collection products combines innovation in performance and quality with a new generation of diverse nanoemulsion products that offer preservative-free, organic, “clean and green,” all-natural wellness solutions. The first product available under […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Reports Initial Offering in Uncle Bud’s New Premium Collection Sees ‘Enthusiastic Customer Response’

April 2, 2024

Pressure BioSciences (OTCQB: PBIO) and its wholly owned subsidiary, Uncle Bud’s, are reporting significant sales of it its revolutionary nanoemulsified CBD product: CBD Body Revive Spray; the spray has 1,200 mg of Nano-CBD. CBD Body Revive Spray is the initial product in Uncle Bud’s Premium Collection, which has been an immediate success. The Premium Collection […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Significant Success with Recent Acquisition

February 26, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is releasing information on the growth of its recent acquisition: Uncle Bud’s Health & Wellness. According […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Consolidate All Operations in New Boston-Based Facility

February 15, 2024

Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly enabling, pressure-based instruments and nanoemulsion products and services for the health and wellness, food and beverage, pharmaceutical, and other industries, has achieved a significant milestone in its accelerating growth journey. The company has consolidated its Boston-area […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces New UB Product Line, Plans Investor Teleconference

February 5, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, is hosting a teleconference today. According to the announcement, during the call company officials will discuss […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Upcoming Investor Teleconference to Discuss Key Company Milestones

February 1, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, has scheduled a teleconference. The Feb. 5, 2024, event will focus on PBIO’s current, in-process move […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Closes on Acquisition of Uncle Bud’s in All-Stock Transaction

January 22, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, has closed on the acquisition of natural health and wellness leader Uncle Bud’s (“UB”). The acquisition […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures New Client Launching Around UltraShear(TM) Nanoemulsions Platform

January 18, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced the receipt of an open order agreement. The agreement is for the purchase in 2024 of a minimum of 10,000 bottles (over $300,000) of the company’s […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Tremendous Opportunity Through Strategic Merger, UltraShear

January 16, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, recently entered a definitive agreement to acquire renowned natural health and wellness leader Uncle Bud’s. Today, the company announced the beginning of summer season order filling with one […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Moves to Acquire Uncle Bud’s, Accelerate UltraShear(TM) Technology into Multiple Markets

January 11, 2024

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, has entered a definitive agreement to acquire globally renowned natural health and wellness leader Uncle Bud’s. Upon closing of the transaction, the combined company intends to become a […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UltraShear(TM) Platform Featured in Food Technology Article

December 21, 2023

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced a powerful visionary article in the respected industry trade magazine, Food Technology, published by the Institute of Food Technologists (“IFT”). The world’s largest professional scientific non-profit […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Publication of Report Showing Potential for Proprietary UltraShear(TM) Platform

December 13, 2023

Pressure BioSciences (OTCQB: PBIO), a leading developer and provider of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including food and beverage, health and wellness, nutraceuticals, cosmetics, biotherapeutics and more, is reporting on the publication of a key scientific study. According to the announcement, the study is in […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’

December 1, 2023

Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. The company, together with the Veterans Service Team (“VST”), a self-funded, 501(c)(3) non-profit company dedicated to the support and wellness […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q3 2023 Financial Report, Business Update

November 21, 2023

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty-testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, is reporting company financial results for the third quarter ended Sept. 30, 2023. The company also released a business update and limited […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2023 Results, Provide Business Update

November 20, 2023

Pressure BioSciences (OTCQB: PBIO) today announced that it will host a teleconference to discuss its third quarter 2023 financial results and to provide a business update. The teleconference, set to take place at 4:30 p.m. ET on Tuesday, Nov. 21, 2023, will include a company presentation followed by a question and answer period. To attend […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Nano CB ‘Vastly Outperforms Current Technologies,’ According to Independent Study

November 9, 2023

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, agrochemical, and other industries has received “powerful scientific validation” through an independent peer-reviewed scientific study. According to the announcement, globally renowned cannabis/natural products researcher […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) BaroFold Technology Platform Featured at International Bioprocess Conference

November 2, 2023

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, is collaborating with scientists from Lonza Biologics. According to the announcement, the two companies are working to present convincing […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Exclusive Distribution Agreement with Premier India Distributor in Life Sciences Space

October 18, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has partnered with Bioscreen Instruments PVT LTD through an exclusive instrument and consumables distribution agreement for India. Bioscreen is […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures First Canadian Patent for Revolutionary UltraShear(TM) Platform

October 10, 2023

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global pharmaceuticals, nutraceuticals, cosmeceuticals, food/beverage and other industries. The company today announced the award of the first Canadian patent for its revolutionary UltraShear(TM) Technology (“UltraShear(TM)” or “USTTM”) […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures 10X Increase in Existing VST Purchase Order

September 22, 2023

Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, and other industries. PBIO, together with the Veterans Service Team (“VST”) (www.vst.org), a self-funded, 501(c)3 non-profit company dedicated to the support and wellness […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Begins Fulfillment of UltraShear Nano-CBD Orders

September 21, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has completed the initial expansion of its launch-phase manufacturing capacity. In addition, the company has completed a review of […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces ‘Key Transition’ Focused on Sale, Installation, Qualification of BaroFold Manufacturing System

September 8, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biopharmaceuticals, nutraceuticals, cosmeceuticals, food and beverage, and other industries, is making an adjustment in its business approach. The company has announced “a key transition in its collaborations with multiple leaders […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Progress Report on UltraShear Nano-CBD Launch, Commercialization Program

August 30, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has released an update regarding launch progress and commercialization program for its revolutionary, best-in-class Nano-CBD product; the product is […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q2 2023 Financial Results, Business Update

August 22, 2023

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries, today released financial results for the second quarter ended June 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Hosts Webinar Showcasing Revolutionary UltraShear Platform

August 17, 2023

Pressure BioSciences (OTCQB: PBIO) today announced that its CEO and President Richard T. Schumacher and Director of Marketing and Sales John B. Hollister are the featured speakers at an online webinar scheduled for 11 a.m. ET on Thursday, Aug. 17, 2023. The webinar will showcase an overview of Pressure BioSciences and its core technologies and […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Gratifying ‘Tip of the Iceberg’ Start of Accelerated UltraShear(TM) Nano-CBD Orders

August 9, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries, today announced strongly accelerating orders for its UltraShear(TM)-processed Nano-CBD topical spray product. According to the update, the company has received seven […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Significant Increase in UltraShear-Processed Nanoemulsions

July 26, 2023

Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food/beverage, and other industries. The company today announced that Canopy CBD Farms LLC (“CCF”), PBIO’s master distributor for cannabis products in North America, has reported a […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Launches Program to Evaluate UltraShear(TM) Technology to Preserve Quality of Fresh Produce

July 25, 2023

Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide food and beverage, agrochemicals, nutraceuticals and other industries. The company today announced the initiation of studies to evaluate and demonstrate its UltraShear Technology(TM) (“UltraShear(TM)”) platform for producing oil-in-water nanoemulsions […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Phase 2 of Commercialization of Its UltraShear(TM)-Processed Nano-CBD Topical Spray

July 17, 2023

Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company has announced, in an interview with renowned cannabis business authority Jeffrey Friedland, that PBIO is advancing into phase […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Distribution Agreement with CdC for UltraShear Processed Nano-CBD Topical Spray

July 10, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, has announced a partnership with Crème de Canna (“CdC”). According to the announcement, the two companies have entered a […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Key Academic Publication Validates Platform’s Impact in Clean-Label Functional Foods & Beverages

July 6, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, is reporting that its UltraShear(TM) Technology platform delivers transformational capabilities that address leading industry and consumer trends in food […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates for Development and Distribution of UltraShear(TM)-Enhanced Products

July 5, 2023

Pressure BioSciences (OTCQB: PBIO) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries. The company today announced its entry into an agreement with Somalab International LLC, a Texas-based leading supplier of novel health […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Webinar, Reports on Positive Results from Third Round of Consumer Testing

June 27, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis, and other industries, has scheduled an online webinar today at 4:30 p.m. ET. The webinar will feature PBIO president and CEO Richard […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Agreement to Provide VST Members with UltraShear Nano-CBD, Other Products

June 13, 2023

Pressure BioSciences (OTCQB: PBIO) has entered a development and supply agreement with the Veterans Service Team (“VST”) to provide world-class, highly effective, and natural wellness products to benefit the mind, body and soul. Set to last five years, the long-term agreement offers VST members exclusive access to custom-designed, hemp-derived, UltraShear-processed nanoemulsions of CBD oil in […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to be Featured on New to The Street Series

June 1, 2023

FMW Media’s business TV show, New to The Street, has announced the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences (OTCQB: PBIO) (“PBI”). According to the announcement, New to The Street’s TV anchors will interview the management team at PBIO with each show airing on its televised […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023

May 16, 2023

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries. The company today reported record quarterly financial results for any fiscal quarter achieved in the first quarter ended March […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes New Opportunities, Looks to ‘Watershed’ Year as Focus Groups Report Impressive Results

May 10, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is reporting on a consumer focus group. The focus group was designed to test a THC Nanoemulsion Oral Spray designed for rapid, direct absorption […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Rapid Progress on Limited Offering of Exclusive THC Licenses for UST(TM) Platform

April 26, 2023

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries, today provided a progress update on its April 21, 2023, announcement. On that day, the company announced its strategic decision to offer up […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Changes to Exclusive UltraShear Nanoemulsion Processing Platform Licenses

April 21, 2023

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals and other industries, is making changes to its license offerings. The company announced a strategic decision to offer up to five exclusive licenses to its patented and […]

InvestorNewsBreaks

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Artisan Industries Inc. Enter Strategic Agreement

April 19, 2023

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products and specialty services to the life sciences field, and Artisan Industries, a worldwide leader in providing purification and separation technologies for the process industries, announced a strategic agreement between the companies. Under the agreement, PBIO […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).